ADAM8 affects glioblastoma progression by regulating osteopontin-mediated angiogenesis

Loss and rescue of osteocalcin and osteopontin modulate osteogenic and angiogenic features of mesenchymal stem/stromal cells

(2020) Marta S. Carvalho et al.   JOURNAL OF CELLULAR PHYSIOLOGY

ADAM8 in invasive cancers: links to tumor progression, metastasis, and chemoresistance

(2019) Catharina Conrad et al.   CLINICAL SCIENCE

New Insights Into Implementation of Mesenchymal Stem Cells in Cancer Therapy: Prospects for Anti-angiogenesis Treatment

(2019) Mohammad Reza Javan et al.   Frontiers in Oncology

ADAM8 expression in breast cancer derived brain metastases: Functional implications on MMP-9 expression and transendothelial migration in breast cancer cells

(2017) Catharina Conrad et al.   INTERNATIONAL JOURNAL OF CANCER

Macrophages form functional vascular mimicry channels in vivo

(2016) Faith H. Barnett et al.   Scientific Reports

ADAM8 as a drug target in pancreatic cancer

(2015) Uwe Schlomann et al.   Nature Communications

ADAM8 expression in invasive breast cancer promotes tumor dissemination and metastasis

(2013) Mathilde Romagnoli et al.   EMBO Molecular Medicine

STAT3 silencing inhibits glioma single cell infiltration and tumor growth

(2013) M. Priester et al.   NEURO-ONCOLOGY

Overexpression of osteopontin induces angiogenesis of endothelial progenitor cells via the avβ3/PI3K/AKT/eNOS/NO signaling pathway in glioma cells

(2011) Yingyi Wang et al.   EUROPEAN JOURNAL OF CELL BIOLOGY

Improved survival time trends for glioblastoma using the SEER 17 population-based registries

(2011) Matthew Koshy et al.   JOURNAL OF NEURO-ONCOLOGY

Overexpression of a disintegrin and metalloprotease 8 in human gliomas is implicated in tumor progression and prognosis

(2011) Shiming He et al.   MEDICAL ONCOLOGY

Identification of Potential Serum Biomarkers of Glioblastoma: Serum Osteopontin Levels Correlate with Poor Prognosis

(2010) P. Sreekanthreddy et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

ADAM8 is a negative regulator of retinal neovascularization and of the growth of heterotopically injected tumor cells in mice

(2010) Victor H. Guaiquil et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

EGFR ligands and their signaling scissors, ADAMs, as new molecular targets for anticancer treatments

(2009) Hiromi Kataoka   JOURNAL OF DERMATOLOGICAL SCIENCE

Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma

(2009) F. M. Iwamoto et al.   NEUROLOGY

Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells

(2009) J Dai et al.   ONCOGENE